<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Muhammad Chairul</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Effectiveness of Radish (Raphanus sativus) Extract In Reducing Tnf-α and Nitrit Oxida levels in Tipe II DM Mice Models with Traumatic Brain Injury</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Diabetes mellitus</style></keyword><keyword><style  face="normal" font="default" size="100%">Nitric oxide</style></keyword><keyword><style  face="normal" font="default" size="100%">Raphanus sativus</style></keyword><keyword><style  face="normal" font="default" size="100%">TNF-α</style></keyword><keyword><style  face="normal" font="default" size="100%">Traumatic Brain Injury</style></keyword><keyword><style  face="normal" font="default" size="100%">Wistar rats.</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2025</style></year><pub-dates><date><style  face="normal" font="default" size="100%">September 2025</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">17</style></volume><pages><style face="normal" font="default" size="100%">597-601</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;The devastating effects of traumatic brain injury (TBI) are fatal, and there is no effective treatment for primary brain injury, especially in patients with diabetes mellitus (DM). Nitric oxide (NO) is a compound that causes systemic vasodilation; a decrease in NO reduces cerebral blood flow after TBI. There is an increase in TNF-α levels demonstrated by mononuclear cells surrounding the traumatic lesion in the rat brain. &lt;em&gt;Raphanus sativus &lt;/em&gt;(radish) is a root vegetable belonging to the Brassicaceae family, which has anti-diabetic effects by lowering blood glucose levels, reducing lipid peroxidation, and improving brain function, thereby protecting against neurotoxic effects associated with oxidative stress in experimental mouse models. &lt;strong&gt;Objective: &lt;/strong&gt;To evaluate the efficacy of radish extract &lt;em&gt;(Raphanus sativus)&lt;/em&gt; in reducing TNF-α and nitric oxide levels in a rat model of type II diabetes mellitus with traumatic brain injury. Method: This study was an in vivo laboratory experimental study with a post-test only control group design. The study population consisted of 25 Wistar rats, which were then induced with diabetes and subjected to a modified Feeney Model closed head injury. After complete data collection, KGD and ELISA assessments were performed, followed by data analysis. &lt;strong&gt;Results: &lt;/strong&gt;There were significant differences (p&amp;lt;0.05) in serum NO and serum TNF-α levels between the normal group, the 100 mg/kg radish extract group, the 300 mg/kg radish extract group, and the 500 mg/kg radish extract group compared to the negative control group. This indicates that radish extract, starting at a dose of 100 mg/kg, can reduce serum NO and serum TNF-α levels. &lt;strong&gt;Conclusion: &lt;/strong&gt;Radish extract &lt;em&gt;(Raphanus sativus)&lt;/em&gt; is effective in reducing TNF-α and nitric oxide levels in a Wistar rat model of type II DM with traumatic brain injury.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">597</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Muhammad Chairul&lt;sup&gt;1*&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Medical Science Faculty of Medicine, Dentistry, and Health Sciences, Universitas Prima Indonesia, Medan, INDONESIA&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Sayeli Vinaykumar</style></author><author><style face="normal" font="default" size="100%">Urval Pundarik Rathnakar</style></author><author><style face="normal" font="default" size="100%">Ullal Sheetal Dinkar</style></author><author><style face="normal" font="default" size="100%">Kamath Priyanka</style></author><author><style face="normal" font="default" size="100%">Tiwary Gaurav</style></author><author><style face="normal" font="default" size="100%">Shenoy Ashok Kudgi</style></author><author><style face="normal" font="default" size="100%">Revappala Sekhar Nishith</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Anti-inflammatory activity of BCM-95 (bio-enhanced formulation of turmeric with increased bioavailabilty) compared to Curcumin in Wistar rats</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Anti-Inflammatory agents</style></keyword><keyword><style  face="normal" font="default" size="100%">Bioavailability</style></keyword><keyword><style  face="normal" font="default" size="100%">Curcumin</style></keyword><keyword><style  face="normal" font="default" size="100%">Inflammation</style></keyword><keyword><style  face="normal" font="default" size="100%">Wistar rats.</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style  face="normal" font="default" size="100%">June/2016</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">8</style></volume><pages><style face="normal" font="default" size="100%">380-384</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align:justify&quot;&gt;&lt;strong&gt;Objective&lt;/strong&gt;: To evaluate anti-inflammatory activity of bioenhanced turmeric formulation (BCM-95) compared to commercial Curcumin formulation (Curcuminoids 95%) in Carrageenan-induced acute inflammatory model. &lt;strong&gt;Materials and Methods&lt;/strong&gt;: Thirty six Wistar rats were divided into six groups-Normal control (2 ml of vehicle), Standard control (Indomethacin 10 mg/kg), 2 doses of BCM 95 (10 and 20 mg/kg) and Curcuminoids 95% (10 and 20 mg/kg). Paw volume was measured using a digital plethysmometer. Vehicle or test drugs were given to rats 30 min before carrageenan administration. Baseline paw volume reading (V&lt;sub&gt;0&lt;/sub&gt;) was noted just prior to administration of 0.1 ml of 1% carrageenan to right hind paw of the rat. Test paw volume readings (V&lt;sub&gt;t&lt;/sub&gt;) were measured at 30, 60, 120, 180, 240, 300 and 360 min, after carrageenan injection. Oedema expressed as increased paw volume (v&lt;sub&gt;t&lt;/sub&gt;-v&lt;sub&gt;0&lt;/sub&gt;) was noted and percentage inhibition of oedema was calculated for all treatment groups. &lt;strong&gt;Statistical analysis&lt;/strong&gt;: Difference between groups were analyzed with ANOVA followed by Tukey test. &lt;strong&gt;Results:&lt;/strong&gt; All treatment groups demonstrated significant (p&amp;lt;0.05) anti-inflammatory activity (oedema suppression) compared to normal control&lt;strong&gt;. &lt;/strong&gt;Anti-inflammatory activity of BCM 95 treated groups were comparable to standard control group except at certain time points, whereas the same activity at all-time points with Curcuminoid 95% treated groups were significantly less than standard control group. Percentage inhibition of paw oedema was maximum with standard control group followed by BCM 95 treated groups followed by Curcuminoid 95% treated groups. &lt;strong&gt;Conclusion:&lt;/strong&gt; BCM 95 treated groups showed significant anti-inflammatory activity compared to Curcuminoid 95% treated groups.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">380</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Sayeli Vinaykumar&lt;sup&gt;1&lt;/sup&gt;, Urval Pundarik Rathnakar&lt;sup&gt;2&lt;/sup&gt;, Ullal Sheetal Dinkar&lt;sup&gt;1&lt;/sup&gt;*, Kamath Priyanka&lt;sup&gt;1&lt;/sup&gt;, Tiwary Gaurav&lt;sup&gt;1&lt;/sup&gt;, Ashok Shenoy Kudgi&lt;sup&gt;1&lt;/sup&gt;, Revappala Sekhar Nishith&lt;sup&gt;3&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Pharmacology, Kasturba Medical College, Mangaluru, Manipal University, Manipal, INDIA.&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Pharmacology, Kanachur Institute of Medical Sciences, Deralakatte, Mangaluru. 575018, INDIA.&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Scoop Med Inc, Bengaluru, INDIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Tchimene Kenne Michel</style></author><author><style face="normal" font="default" size="100%">Anaga Arua Ottoh</style></author><author><style face="normal" font="default" size="100%">Ugwoke Christopher Emeka Chukwunonye</style></author><author><style face="normal" font="default" size="100%">Ezugwu Christopher Obodoike</style></author><author><style face="normal" font="default" size="100%">Okunji Christopher</style></author><author><style face="normal" font="default" size="100%">Iwu Maurice Mmaduakolam</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Bio-Flavonoids and Garcinoic Acid from Garcinia kola Heckel Seeds with Promising Antioxidant Potentials</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Anti-inflammatory</style></keyword><keyword><style  face="normal" font="default" size="100%">Carrageenan</style></keyword><keyword><style  face="normal" font="default" size="100%">Garcinia kola</style></keyword><keyword><style  face="normal" font="default" size="100%">Paw edema</style></keyword><keyword><style  face="normal" font="default" size="100%">Wistar rats.</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style  face="normal" font="default" size="100%">09/2015</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">8</style></volume><pages><style face="normal" font="default" size="100%">56-58</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Objective:&lt;/strong&gt; The research was carried out to investigate the anti-inflammatory effect of ethanol extract, fraction (kolaviron) and compounds (garcinoic acid, GB1 and GB2) of &lt;em&gt;Garcinia kola&lt;/em&gt; seeds. &lt;strong&gt;Materials and Method:&lt;/strong&gt; To evaluate the acute anti-inflammatory effect of extract, fraction and compounds of &lt;em&gt;G. kola&lt;/em&gt; carrageenan-induced edema model in wistar albino rats was used. &lt;strong&gt;Results:&lt;/strong&gt; Kolaviron (50 mg/kg), garcinoic acid (50 mg/kg) and the crude extract (50 mg/kg) caused 100, 83 and 74% inhibition of carrageenan-induced paw edema respectively at 6 h post administration. Indomethacin (10 mg/ kg), the reference drug induced 100% inhibition of carrageenan-induced paw oedema. While GB1 (50 mg/kg) and GB2 (50 mg/kg) was prominent at 4, 5 and 6 h post administration. &lt;strong&gt;Conclusion:&lt;/strong&gt; Results showed that the extract possessed anti-inflammatory activity, which have justified their use in Nigeria traditional medicine to treat inflammation.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">56</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Tchimene Kenne Michel&lt;sup&gt;1,3*&lt;/sup&gt;, Anaga Arua Ottoh&lt;sup&gt;2&lt;/sup&gt;, Ugwoke Christopher Emeka Chukwunonye&lt;sup&gt;3&lt;/sup&gt;, Ezugwu Christopher Obodoike&lt;sup&gt;3&lt;/sup&gt;, Okunji Christopher&lt;sup&gt;1&lt;/sup&gt; and Iwu Maurice Mmaduakolam&lt;sup&gt;1&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;International Centre for Ethnomedicine and Drug Development, 110 Aku Road, Nsukka, Nigeria.&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Veterinary Physiology and Pharmacology, Faculty of Veterinary Medicine, UNN, Nsukka, Nigeria.&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of pharmacognosy and Environmental Medicine, UNN, Nsukka, Nigeria.&lt;/p&gt;</style></auth-address></record></records></xml>